首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

尿道感染檢測市場規模、佔有率和成長分析（按檢測套組、感染疾病類型、檢測類型、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902067

尿道感染檢測市場規模、佔有率和成長分析（按檢測套組、感染疾病類型、檢測類型、最終用戶和地區分類）－2026-2033年產業預測

Urinary Tract Infection Testing Market Size, Share, and Growth Analysis, By Test Kit (Home Test Kits, Laboratory Test Kits), By Infection Type, By Test Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球尿道感染檢測市場規模將達到 6.3827 億美元，到 2025 年將達到 6.6763 億美元，到 2033 年將達到 9.5673 億美元，預測期（2026-2033 年）的複合年成長率為 4.6%。

全球尿道感染(UTI) 檢測市場正經歷顯著成長，這主要得益於診斷技術的進步和人們對泌尿道感染（主要影響女性）日益成長的認知。推動該市場成長的關鍵因素包括尿路感染發病率的上升、醫療費用支出的增加以及人口老化導致老年人更容易感染此類感染疾病。技術創新催生了更精準高效的診斷工具，例如就地檢驗和非侵入性技術，從而促進了泌尿道感染的檢測和管理。此外，個人化醫療的趨勢也促使醫療機構採用先進的診斷解決方案，進一步推高了市場需求。然而，儘管醫療保健行業普遍重視感染疾病控制，但某些檢測方法的準確性以及替代治療方案的挑戰可能會阻礙因素市場擴張。

推動全球尿道感染檢測市場發展的因素

全球尿道感染檢測市場成長的主要驅動力是抗生素抗藥性尿道感染發生率的上升。抗生素的不合理使用導致了抗藥性菌株的出現，進一步加劇了尿道感染的治療難度。這項嚴峻挑戰促使人們對精準診斷方法的需求日益成長，包括尿液培養和藥敏試驗，這些方法能夠幫助醫療專業人員根據特定致病菌選擇最有效的治療方法。此外，應對抗生素抗藥性的迫切需求也推動了對新治療方法研發的投資，促使市場尋求創新解決方案來對抗抗藥性尿道感染，同時倡導合理使用抗生素。

全球尿道感染檢測市場面臨的限制因素

由於抗生素抗藥性問題，全球尿道感染(UTI) 檢測市場面臨嚴峻挑戰。抗生素的不合理使用和過度處方導致抗藥性細菌數量增加，降低了傳統 UTI 療法的療效。這一持續存在的問題使治療環境更加複雜，導致感染持續時間延長、醫療成本上升以及嚴重併發症風險增加。醫療專業人員被要求謹慎管理抗生素的使用，以確保有效治療，同時倡導合理的處方實踐。因此，人們對創新治療方案和先進診斷方法的需求日益成長，以應對這一重大的公共衛生挑戰。

全球尿道感染檢測市場趨勢

在全球尿道感染(UTI) 檢測市場中，照護現場(POC) 解決方案的採用率顯著提高，這主要得益於對快速高效診斷的需求。這些 POC 方法使醫療服務提供者能夠繞過傳統的檢查室流程，在診療現場即可獲得即時結果，從而顯著縮短等待檢測結果的時間。這一趨勢在基層醫療機構尤其有利，因為快速診斷對於有效治療至關重要。 POC 技術的準確性和效率不斷提高，使醫療專業人員能夠更快地做出更明智的決策，從而改善患者預後並最佳化醫療資源。隨著這些創新技術的普及，它們正在從根本上重新定義全球 UTI 的診斷方式。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Becton, Dickinson and Company（BD）（USA）
bioMerieux SA（France）
Thermo Fisher Scientific Inc.（USA）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Bio-Rad Laboratories, Inc.（USA）
Cepheid（USA）（Parent Company：Danaher Corporation）
Hologic, Inc.（USA）
Quidel Corporation（USA）
Meridian Bioscience, Inc.（USA）
Luminex Corporation（USA）
QIAGEN NV（Netherlands）
Beckman Coulter, Inc.（USA）（Parent Company：Danaher Corporation）
Sysmex Corporation（Japan）
OraSure Technologies, Inc.（USA）
GenMark Diagnostics, Inc.（USA）
Mesa Biotech, Inc.（USA）
Alere Inc.（USA）（Parent Company：Abbott Laboratories）
T2 Biosystems, Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2169

Global Urinary Tract Infection Testing Market size was valued at USD 638.27 Million in 2024 and is poised to grow from USD 667.63 Million in 2025 to USD 956.73 Million by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

The global urinary tract infection (UTI) testing market is experiencing significant growth, driven by advancements in diagnostic technologies and heightened awareness of UTIs, which predominantly affect women. Key factors fueling this market include the increasing incidence of UTIs, rising healthcare expenditures, and an aging population that is more vulnerable to such infections. Innovations in technology are yielding more accurate and efficient diagnostic tools, such as point-of-care tests and non-invasive techniques, facilitating better detection and management of UTIs. Additionally, the trend towards personalized healthcare encourages providers to embrace advanced diagnostic solutions, further increasing demand. Nevertheless, challenges related to the accuracy of certain testing methods and alternative treatment options may pose constraints on market expansion, despite a general focus on infection management within the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinary Tract Infection Testing Market Segments Analysis

Global Urinary Tract Infection Testing Market is segmented by Test Kit, Infection Type, Test Type, End User and region. Based on Test Kit, the market is segmented into Home Test Kits and Laboratory Test Kits. Based on Infection Type, the market is segmented into Urethritis, Cystitis and Pyelonephritis. Based on Test Type, the market is segmented into Urinalysis, Urine Cultures and Susceptibility Testing. Based on End User, the market is segmented into General Practitioners (GPs), Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinary Tract Infection Testing Market

The global market for urinary tract infection testing is largely propelled by the rising incidence of antibiotic-resistant UTIs. The inappropriate use of antibiotics has resulted in the development of resistant bacterial strains, making UTI management increasingly complex. This critical issue has created a demand for precise diagnostic methods, including urine cultures and susceptibility testing, which allow healthcare professionals to determine the most effective treatment options based on the specific bacteria involved. Furthermore, the pressing need to address antibiotic resistance has stimulated investment in research and development for new therapies, guiding the market towards innovative solutions that tackle resistant UTIs while encouraging responsible antibiotic usage.

Restraints in the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market faces notable challenges due to antibiotic resistance. The inappropriate use and over-prescription of antibiotics have resulted in the rise of drug-resistant bacteria, diminishing the efficacy of traditional treatments for UTIs. This ongoing issue complicates the treatment landscape, leading to prolonged infections, heightened medical expenses, and the potential for serious complications. Healthcare professionals are required to carefully manage the use of antibiotics, ensuring effective treatment while promoting responsible prescribing practices. As a result, there is an increasing demand for innovative therapeutic solutions and advanced diagnostic methods to address this critical public health challenge.

Market Trends of the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market is witnessing a significant shift towards the adoption of Point-of-Care (POC) testing solutions, driven by the need for rapid and efficient diagnostics. These POC methods enable healthcare providers to deliver immediate results at the site of care, bypassing traditional laboratory processes and significantly shortening turnaround times. This trend is particularly beneficial in primary care environments where quick diagnosis is crucial for effective treatment. Enhanced accuracy and efficiency of POC technologies are empowering healthcare professionals to make informed decisions swiftly, thereby improving patient outcomes and optimizing healthcare resources. As these innovations proliferate, they are fundamentally redefining UTI diagnostic practices worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Urinary Tract Infection Testing Market Size by Test Kit & CAGR (2026-2033)

Market Overview
Home Test Kits
Laboratory Test Kits

Global Urinary Tract Infection Testing Market Size by Infection Type & CAGR (2026-2033)

Market Overview
Urethritis
Cystitis
Pyelonephritis

Global Urinary Tract Infection Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Urinalysis
Urine Cultures
Susceptibility Testing

Global Urinary Tract Infection Testing Market Size by End User & CAGR (2026-2033)

Market Overview
General Practitioners (GPs)
Urologists
Urogynecologists
Hospital Laboratories
Reference Laboratories
Hospital Emergency Departments
Urgent Care
Others

Global Urinary Tract Infection Testing Market Size & CAGR (2026-2033)

North America (Test Kit, Infection Type, Test Type, End User)
- US
- Canada
Europe (Test Kit, Infection Type, Test Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Kit, Infection Type, Test Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Kit, Infection Type, Test Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Kit, Infection Type, Test Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid (USA) (Parent Company: Danaher Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (USA) (Parent Company: Danaher Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mesa Biotech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (USA) (Parent Company: Abbott Laboratories)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
T2 Biosystems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments